Gala Pharmaceutical Inc. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 3 rows, 3 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2016-01-27: Reporting owner HAAS JAMES; Form 5; Security Preferred Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2016-01-27: Reporting owner HAAS JAMES; Form 5; Security Preferred Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2016-01-27: Reporting owner Naccarato Owen; Form 5; Security Preferred Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2016-01-27 | HAAS JAMES 10% Owner | 5 | Preferred Stock Non-derivative · Direct · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +258,334 258,334 owned after | $0.00 | 2019-04-19 | |
| 2016-01-27 | HAAS JAMES 10% Owner | 5 | Preferred Stock Non-derivative · Indirect · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $0.00 | 2019-04-19 | |
| 2016-01-27 | Naccarato Owen 10% Owner | 5 | Preferred Stock Non-derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +166,666 166,666 owned after | $0.00 | 2019-04-17 |